AIM-PDL1
Various Cancers (Immunotherapy Biomarker)
Key Facts
About PathAI
PathAI is a leading AI-powered pathology company that has developed a comprehensive platform, AISight®, for digital pathology image management and AI algorithm deployment. It serves two primary markets: biopharma clients, for whom it provides translational research, clinical trial services, and diagnostic development, and anatomic pathology laboratories, which use its platform for workflow digitization and AI-assisted diagnostics. The company has achieved significant regulatory milestones, including FDA clearance for its AISight® Dx platform for primary diagnosis and FDA qualification for its AIM-MASH tool for clinical trials, and collaborates with major industry players like Labcorp and top biopharma firms.
View full company profile